Close

Amedra re-launches Adrenaclick to treat anaphylaxis

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

How Refurbished Gear Is De-Risking Early-Stage Pharma R&D

Early-stage pharmaceutical companies invest heavily in discovery and development...

Novo Nordisk and Orbis Medicines Partner on Oral Therapies for Cardiometabolic Diseases

Danish pharmaceutical company Novo Nordisk and biotechnology developer Orbis...
- Advertisement -

Amedra Pharmaceuticals has re-launched a single-dose epinephrine auto-injector Adrenaclick for people with increased risk of anaphylaxis in both 0.15mg and 0.30mg strengths.

Potentially life-threatening allergic reaction, Anaphylaxis onsets rapidly and may cause severe swelling, breathing problems, loss of blood pressure, and death.

Indicated for the treatment of allergic reactions, Adrenaclick will be made available in 0.15mg and 0.30mg doses as two-pack carton.

The emergency injection (shot) of epinephrine is used for allergic reactions caused due to stinging and biting insects (bugs), allergy injections, food, medicines, exercise, or unknown causes.

 

World Pharma Today brings together the global pharmaceutical industry — from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives — through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

How Refurbished Gear Is De-Risking Early-Stage Pharma R&D

Early-stage pharmaceutical companies invest heavily in discovery and development...

Novo Nordisk and Orbis Medicines Partner on Oral Therapies for Cardiometabolic Diseases

Danish pharmaceutical company Novo Nordisk and biotechnology developer Orbis...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »